DBS and Heritas Capital today announced the successful first close of the Asia Impact First Fund (AIFF), which was launched last August with an investment mandate to support innovative and high-growth social enterprises in the region. The fund has raised over USD 20 million – led by anchor investor...
Veradigm Inc., formerly Allscripts Healthcare Solutions, Inc., announced today an investment in Holmusk, a global behavioral health real-world evidence and data analytics company, as part of Holmusk’s $45 million series B financing round. The round was led by Veradigm, with participation from current investors including Heritas Capital, Health Catalyst...
Venture capitalists (VCs) are ending 2022 with plenty of capital, but they are in no rush to deploy it. With so many startups right-sizing their operations and adjusting their fundraising expectations, investors are now looking forward to quality opportunities in 2023. “I will say this is a very good time...
Alchemy Foodtech, a Singapore-based food innovation company with a mission to “Make Carbs Good” by reducing carbohydrates, sugar and GI of foods while delivering great taste, raised USD$3million from investors including public-listed Thai President Foods, Pine Venture Partners and Selera Kapital, an investment arm of Sour Sally Group. Existing...
The rapid pace of medical innovation and transformation during the Covid-19 pandemic radically changed how Singapore-based investor Chik Wai Chiew imagined he and his company could have an impact on society. The CEO and executive director of Heritas Capital, a private-equity and venture-capital (VC) company, realised it was essential to...
Heritas Capital1 announces the launch of Asia Impact First Fund (AIFF), with a proposed fund size of US$50 million, to back 10 to 15 innovative and high-growth social enterprises across Asia. AIFF will provide growth capital to social enterprises with a clear and demonstrated social and/or environmental impact, and...
